Centre Hospitalier Universitaire
Toulouse, France
NCT Number: NCT02809560
Asthma affects about 10% of children and 6% of adults in industrialized countries. Lymphocytes (L) Th2, a T cell population (LT) producing interleukin (IL) -4, 5 and 13 are broadly involved in this pathology in experimental models and in humans. Many studies show that the signaling pathways activated by the commitment of T receiver differ depending LT. The identification of specific signaling pathways links to Th2 offer new therapeutic approaches. Precedent study showed that mouse Th2 selectively expressed related to calcium channels sensitive channels Cav1 voltage, normally found in excitable cells where they are defined as receivers dihydropyridine (DHP).
The goal of the present study is to show the presence of Cav1 channels in inflammatory cells in allergic asthmatics and show overexpression of these channels in the peripheral blood mononuclear cells from asthmatic subjects before and / or after stimulation with the TCR in comparison with controls.
Looking for future studies?
Notify Me6 year–18 year
All sexes
Interventional
Not applicable
Toulouse, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Asthmatic children arm :
For control children arm :
Exclusion criteria
For both arms:
For asthmatic children arm :
Collection of expectoration in sterile vial, conserved in ice all along the examination
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
University Hospital, Toulouse
Other
Acronym: CAVASTHME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05091034
Asthma, Bronchial Diseases
New York, United States
View Trial DetailsNCT05853809
Asthma, Bronchial Diseases
Stockholm, Sweden
View Trial DetailsNCT07825441
Asthma, Bronchial Diseases
Portsmouth, Hampshire, United Kingdom
View Trial DetailsNCT05168995
Asthma, Bronchial Diseases
Mestre, VE, Italy
View Trial Details